A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes

Clinical trial NCT03746041 · COMPLETED

Trial details

NCT number: NCT03746041
Sponsor: University of Rochester
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia

Start date: 2019-02-14
Primary completion: 2022-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.